| Date Filed | Type | Description |
| 08/23/2023 |
SC 13D
| Camac Fund, LP reports a 4.3% stake in Forte Biosciences, Inc. |
| 08/03/2023 |
SC 13D/A
| Camac Fund, LP reports a 3.6% stake in Forte Biosciences Inc. |
| 07/27/2023 |
SC 13D/A
| Camac Fund, LP reports a 13.9% stake in Gold Reserve Inc. |
| 07/05/2023 |
SC 13D/A
| Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc. |
| 05/31/2023 |
SC 13D/A
| Camac Fund, LP reports a 19.7% stake in Ambase Corp. |
| 05/25/2023 |
SC 13D/A
| Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc. |
| 03/02/2023 |
SC 13G/A
| Camac Fund, LP reports a 13.5% stake in Impac Mortgage Holdings, Inc. |
| 02/21/2023 |
SC 13D/A
| Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc. |
| 01/10/2023 |
SC 13D/A
| Camac Fund, LP reports a 0% stake in Pasithea Therapeutics Corp. |
| 12/13/2022 |
SC 13D/A
| Camac Fund, LP reports a 6.1% stake in Pasithea Therapeutics Corp. |
| 11/08/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/03/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/01/2022 |
SC 13D/A
| Camac Fund, LP reports a 6.7% stake in Pasithea Therapeutics Corp. |
| 10/25/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/28/2022 |
SC 13D/A
| Camac Fund, LP reports a 8.2% stake in Forte Biosciences Inc. |
| 09/06/2022 |
SC 13D/A
| Camac Fund, LP reports a 6.4% stake in Pasithea Therapeutics Corp. |
| 09/01/2022 |
SC 13D/A
| Camac Fund, LP reports a 6.1% stake in Pasithea Therapeutics Corp. |
| 08/18/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/17/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/08/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/01/2022 |
SC 13D
| Camac Fund, LP reports a 7.5% stake in Forte Biosciences, Inc. |
| 07/27/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/27/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/24/2022 |
SC 13D/A
| Camac Fund, LP reports a 4.4% stake in Pasithea Therapeutics Corp. |
| 06/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/13/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/01/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 03/15/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/19/2022 |
SC 13D/A
| Camac Fund, LP reports a 9.3% stake in Cedar Realty Trust, Inc. |
| 12/08/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/29/2021 |
SC 13D/A
| Camac Fund, LP reports a 13.5% stake in Liberated Syndication Inc. |
|